Longitudinal Development of Behavior and Its Underlying Neural Correlates in Human Infants
NCT ID: NCT05167565
Last Updated: 2026-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2022-10-17
2026-01-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cracking the Code of Crying Babies: How Familiarity Changes the Interpretation of Cries
NCT05170178
Development of Attentional Biases for Affective Cues in Infants of Mothers With Depression
NCT06835855
Perception of Baby's Painful Cry in fMRI
NCT03190486
Early Brain Development in Twins
NCT01409746
The Psychobiology of Childhood Temperament
NCT00060775
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Infants aged around 3 month
80 infants aged around 3 months will be included in this study up to around 12.5 months
MRI/DTI
High resolution MRI scans will be acquired from each infant at three time points (\~3, 6, and 12 months), while they are naturally asleep to measure the progressive myelination of the major brain fiber tracks, grey matter maturation, and to create generative models for source reconstruction of EEG sensor data.
EEG
EEG will be used to record infant brain activity during reaching and grasping actions to analyze beta activity
Eye Tracking
Infants will be presented with the experimental stimuli, which will consist of images of adults displaying different facial expressions and non-social images (e.g. a cross, a geometric pattern). This procedure is based on commonly used eye tracking paradigms designed to assess attention biases in infancy. Infant eye movement and position will be measured during stimuli presentation.
Ages and Stages Questionnaire (ASQ)
The parents will be asked to complete the ASQ questionnaire (Developmental questionnaire).
ASQ-3 has 5 aspects: Communication, Gross motor, Fine motor, Problem solving and Personal-Social Each aspect has 6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0. ASQ-3 average = average score of 5 aspects.
Infant Behavior Questionnaire Revised (IBQ-R)
The parents will be asked to complete the IBQ-R questionnaire (Developmental questionnaire).
The 191-item instrument provides scores on 14 temperament scales which in turn cluster into 3 overarching factors: Positive Affectivity/Surgency, Negative Emotionality, and Orienting/Regulatory Capacity. Items are rated on a 7-point scale.
Beck Depression Inventory (BDI)
The parents will be asked to complete the BDI questionnaire (Mental health questionnaire).
Scale is a 21-item self-reported questionnaire which measures the existence and severity of symptoms of depression. Scores for each symptom are added up to obtain the total scores for all 21 items. Total score ranges from 0-63; of which 0-8 is considered no depression, 0-13 is minimal depression, 14-19 is mild depression, 20-28 is moderate depression and 29-63 is severe depression.
The Brief Fear of Negative Evaluation Scale (BFNE)
The parents will be asked to complete the BFNE questionnaire (Mental health questionnaire).
The BFNE measures anxiety associated with perceived negative evaluation. This scale is composed of 12 items describing fearful or worrying cognition. Scores from for each item are added up to obtain the total score.
Edinburgh Postnatal Depression Scale
The parents will be asked to complete the Edinburgh Postnatal Depression Scale (Mental health questionnaire).
This is a set of 10 screening questions that can indicate whether a parent has symptoms that are common in women with depression and anxiety during pregnancy and in the year following the birth of a child. The total score is calculated by adding the numbers selected for each of the 10 items. If the parent's score is 10 points or above, they should speak to a health professional about those symptoms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI/DTI
High resolution MRI scans will be acquired from each infant at three time points (\~3, 6, and 12 months), while they are naturally asleep to measure the progressive myelination of the major brain fiber tracks, grey matter maturation, and to create generative models for source reconstruction of EEG sensor data.
EEG
EEG will be used to record infant brain activity during reaching and grasping actions to analyze beta activity
Eye Tracking
Infants will be presented with the experimental stimuli, which will consist of images of adults displaying different facial expressions and non-social images (e.g. a cross, a geometric pattern). This procedure is based on commonly used eye tracking paradigms designed to assess attention biases in infancy. Infant eye movement and position will be measured during stimuli presentation.
Ages and Stages Questionnaire (ASQ)
The parents will be asked to complete the ASQ questionnaire (Developmental questionnaire).
ASQ-3 has 5 aspects: Communication, Gross motor, Fine motor, Problem solving and Personal-Social Each aspect has 6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0. ASQ-3 average = average score of 5 aspects.
Infant Behavior Questionnaire Revised (IBQ-R)
The parents will be asked to complete the IBQ-R questionnaire (Developmental questionnaire).
The 191-item instrument provides scores on 14 temperament scales which in turn cluster into 3 overarching factors: Positive Affectivity/Surgency, Negative Emotionality, and Orienting/Regulatory Capacity. Items are rated on a 7-point scale.
Beck Depression Inventory (BDI)
The parents will be asked to complete the BDI questionnaire (Mental health questionnaire).
Scale is a 21-item self-reported questionnaire which measures the existence and severity of symptoms of depression. Scores for each symptom are added up to obtain the total scores for all 21 items. Total score ranges from 0-63; of which 0-8 is considered no depression, 0-13 is minimal depression, 14-19 is mild depression, 20-28 is moderate depression and 29-63 is severe depression.
The Brief Fear of Negative Evaluation Scale (BFNE)
The parents will be asked to complete the BFNE questionnaire (Mental health questionnaire).
The BFNE measures anxiety associated with perceived negative evaluation. This scale is composed of 12 items describing fearful or worrying cognition. Scores from for each item are added up to obtain the total score.
Edinburgh Postnatal Depression Scale
The parents will be asked to complete the Edinburgh Postnatal Depression Scale (Mental health questionnaire).
This is a set of 10 screening questions that can indicate whether a parent has symptoms that are common in women with depression and anxiety during pregnancy and in the year following the birth of a child. The total score is calculated by adding the numbers selected for each of the 10 items. If the parent's score is 10 points or above, they should speak to a health professional about those symptoms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Uncomplicated pregnancy and delivery, APGAR scores \>8
* Full-term birth without identified neuromotor problems at birth
* No congenital or developmental anomalies affecting the brain
* No reported history of neurological disorders or learning disabilities in the infants
* No reported specific visual, developmental and cognitive impairment
* Absence of medication having a cerebral or psychological impact
* Both parents/ legal guardian must provide their consent and signature prior to participation of their infant in the study
Exclusion Criteria
* Infants requiring a corrective surgery
* Any refusal of a parent
* Infants with severe impairment of the general condition and vital functions
* Infants with dermatitis of the face or scalp
* Infants who receive neurological treatment
* Infants born pre-term (birth before 37 weeks gestation)
* Infants whose mothers have significant medical conditions and/or had significant complications during pregnancy
* Infants who are adopted,
* Infants who have a first degree relative with autism, intellectual disability, schizophrenia, or bipolar disorder,
* Infants who have any significant medical and/or genetic conditions affecting growth, development, or cognition,
* Infants who have any contraindication to MRI (metallic object, surgical material like cochlear implant)
* Maternal pre- eclampsia, placental abruption, maternal HIV status, and maternal alcohol or illicit drug use during pregnancy.
3 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut des Sciences Cognitives (ISC) Laboratoire CNRS UMR6229
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A02238-33
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL21_0921
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.